Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research, and pharmaceutical development.

They produce primary and secondary antibodies for:

  • Apoptosis,
  • Cellular Senescence,
  • Bacterial Chemotaxis,
  • Regulation of the Actin Cytoskeleton
  • Autophagy,
  • Endocytosis,
  • Peroxisome,
  • Phagosome,
  • Biofilm Formation,
  • Quorum Sensing,
  • and many other signaling pathways.